Evidence map›Paper›PMID 32258158›Full record

ReviewBioMed research international2020

Quality of Life in Patients with Morphea: A Cross-Sectional Study and a Review of the Current Literature.

Justyna Szczęch, Dominik Samotij, Kamila Jaworecka, Aleksandra Tobiasz, Adam Reich

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Morphea: progress to date and the road ahead.Annals of translational medicine · 2021
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Justyna SzczęchDepartment of Dermatology, University of Rzeszow, Rzeszów, Poland.ORCID https://orcid.org/0000-0002-1524-2817
Dominik SamotijDepartment of Dermatology, University of Rzeszow, Rzeszów, Poland.ORCID https://orcid.org/0000-0002-6594-5369
Kamila JaworeckaDepartment of Dermatology, University of Rzeszow, Rzeszów, Poland.
Aleksandra TobiaszStudents' Scientific Circle of Experimental Dermatology, Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wrocław, Poland.
Adam ReichDepartment of Dermatology, University of Rzeszow, Rzeszów, Poland.ORCID https://orcid.org/0000-0002-5573-1754

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of the study was to evaluate QoL in patients suffering from morphea.

resultsThe mean DLQI scoring was 3.8 ± 4.1 points and the CDLQI was 2.3 ± 3.0. The mean value of Visual Analogue Scale thermometer (EQ VAS) was 66.9 ± 17.5 points. The disease activity of morphea based on mLoSSI correlated significantly with QoL impairment according to the DLQI (

conclusionsEvaluation of QoL in patients with morphea is still challenging due to lack of good assessment tools dedicated specifically for morphea patients. In general, QoL in morphea patients is significantly correlated with the disease activity, but not with disease-induced skin damage.

Indexed as

Quality of LifeScleroderma, LocalizedSurveys and QuestionnairesAdolescentAdultAgedAged, 80 and overChildCross-Sectional StudiesFemaleHumansMaleMiddle AgedProspective Studies

Identifiers

PMID32258158
PMCPMC7094194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.